5UAB
MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody
Summary for 5UAB
Entry DOI | 10.2210/pdb5uab/pdb |
Related | 5UAD 5UAF |
Descriptor | Hepatocyte growth factor receptor, N-{6-[([1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl}cyclopropanecarboxamide, GLYCEROL, ... (5 entities in total) |
Functional Keywords | met, tyrosine kinase, inhibitor, antitumor, transferase-inhibitor complex, transferase/inhibitor |
Biological source | Homo sapiens (Human) |
Cellular location | Membrane; Single-pass type I membrane protein. Isoform 3: Secreted: P08581 |
Total number of polymer chains | 1 |
Total formula weight | 39057.44 |
Authors | Hoffman, I.D.,Lawson, J.D. (deposition date: 2016-12-19, release date: 2017-05-31, Last modification date: 2024-03-06) |
Primary citation | Farrell, P.J.,Matuszkiewicz, J.,Balakrishna, D.,Pandya, S.,Hixon, M.S.,Kamran, R.,Chu, S.,Lawson, J.D.,Okada, K.,Hori, A.,Mizutani, A.,Iwata, H.,de Jong, R.,Hibner, B.,Vincent, P. MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody. Mol. Cancer Ther., 16:1269-1278, 2017 Cited by PubMed: 28341789DOI: 10.1158/1535-7163.MCT-16-0771 PDB entries with the same primary citation |
Experimental method |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)